Immunome Stock Forecast

Sell candidate since May 22, 2026 Loss -8.54%

The Immunome, Inc. stock price gained 2.43% on the last trading day (Wednesday, 3rd Jun 2026), rising from $19.34 to $19.81. During the last trading day the stock fluctuated 4.98% from a day low at $18.89 to a day high of $19.83. The price has risen in 6 of the last 10 days and is up by 0.76% over the past 2 weeks. Volume fell on the last day by -2 million shares and in total, 1 million shares were bought and sold for approximately $24.69 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $19.36 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.03% during the next 3 months and, with a 90% probability hold a price between $20.14 and $26.14 at the end of this 3-month period.

IMNM Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 2.43%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Immunome, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $21.19 and $22.42. A break-up above any of these levels will issue buy signals.

Support, Risk & Stop-loss for Immunome, Inc. stock

Immunome, Inc. finds support from accumulated volume at $19.61 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.94 between high and low, or 4.98%. For the last week, the stock has had daily average volatility of 5.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IMNM) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Immunome, Inc. to open at $19.51, and during the day (based on 14 day Average True Range), to move between $19.19 and $20.43, which gives a possible trading interval of +/-$1.24 (+/-6.48%) up or down from last closing price. If Immunome, Inc. takes out the full calculated possible swing range there will be an estimated 6.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $19.61 (1.01%) than the resistance at $20.01 (1.01%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Immunome, Inc. stock A Buy?

The Immunome, Inc. stock holds several negative signals and despite the positive trend, we believe Immunome, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.801 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $19.51 ( 1.51%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk